Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution... – Containing or obtained from cucumbrits
Reexamination Certificate
2011-01-25
2011-01-25
Flood, Michele (Department: 1655)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
Containing or obtained from cucumbrits
C424S738000, C424S764000, C514S814000
Reexamination Certificate
active
07875301
ABSTRACT:
The provision of a GM-CSF increasing agent or a TNF-α modulator, which is a composition comprisingCucurbita moschata, Carthamus tinctorius, Plantago asiaticaandLonicera japonica; or a health food, nutritional supplementary food, or the like for increase of GM-CSF, and the prevention of Crohn's disease and the like, and the prognosis thereof, which comprisesCucurbita moschata, Carthamus tinctorius, Plantago asiaticaandLonicera japonica.
REFERENCES:
patent: 4421746 (1983-12-01), Kojima et al.
patent: 4456597 (1984-06-01), Kojima et al.
patent: 4469685 (1984-09-01), Kojima et al.
patent: 5753266 (1998-05-01), Youssefyeh et al.
patent: 5882672 (1999-03-01), Kojima et al.
patent: 2813471 (1998-08-01), None
patent: 10-279491 (1998-10-01), None
patent: 11-116498 (1999-04-01), None
patent: 2000-281584 (2000-10-01), None
Nissen et al., Failure of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor Therapy in Aplastic Anemia Patients with Very Severe Neutropenia, 1988, Blood, vol. 72: 2045-2047.
Tropilab http://www.tropilab.com/cucur-max.html.
Unigraz http://www.uni-graz.at/˜katzer/engl/Cart—tin.html.
Herbalremedies http://www.herbalremedies.com/psylliumhusk.html.
USDA http://plants.usda.gov/java/profile?symbol=LOJA.
Weisbart et al., Huamn granulocyte-macrophage colony-stimulating factor is a neutrophil activator, 1985, Nature, 314, 361-363.
Levine et al., Daily subcutaneous recombinant granulocyte-macrophage colony stimulating factor improves the neutropenia induced by azidothymidine in patients with AIDS/ARC; follow up, 1989, Int Conf AIDS, 5, 406.
Falange et al., Neutrophil Activation and Hemostatic Changes in Healthy Donors Receiving Granulocyte Colony-Stimulating Factor, 1999, Blood, 93, 2506-2514.
Mar. 24, 2009 tropilab http://www.tropilab.com/cucur-max.html.
Mar. 24, 2009 Unigraz http://www.uni-graz.at/˜katzer/engl/Cart—tin.html.
Mar. 24, 2009 Herbalremedies http://www.herbalremedies.cim/psylliumhusk.html.
Mar. 24, 2009 USDA http://plants.usda.gov/java/profile?symbol=LOJA.
Baert, F.J. et al., “Tumor Necrosis Factor α-antibody (Infliximab) Therapy Profoundly Down-Regulates the Inflammation in Crohn's Disease,” Gastroenterology (1999) vol. 116, pp. 22-28.
Ehrenpreis, E.D. et al., “Thalidomide Therapy for Patients with Refractory Crohn's Disease: An Open-Label Trial,” Gastroenterology (1997), vol. 117, pp. 1271-1277.
The Merck Manual 16thEdition, p. 1240, 1994.
Mizoguchi, M., “GM-CSF” in Cytokine Therapy: Approach From Basis and Pathema, (1993) Nankodo Co., Ltd., Tokyo p. 39-45, ISBN: 4524233628.
Nicola, N.A., “GM-CSF” in Cytokine Reference a Compendium of Cytokines and Other Mediators of Host Defense, Oppenheim & Feldman, eds., (2001) Academic Press, pp. 899-910.
Takeuchi, T., “Anti-TNF α Therapy” in Separate Volume: Progress of Medical Science, Immunodeficiency, (2002) Ishiyakushuppan Co., Ltd., pp. 538-542.
Urabe, A., “Blood Disease and Cytokine Therapy, Cytokine Therapy Approach from Start and Pathema,” (1993) Nankodo Co., Ltd., Tokyo, pp. 184-194.
Watanabe, N., “Development of Highly Sensitive Assay for Detection of Intravital Trace Materials and Its Clinical Application,” Lab. Clin. Pract. (2002), vol. 20(2), pp. 110-114.
Yamamura, M., “Clinical Analysis and Treatment of Anemia in Patients of Rheumatoid Arthritis,” Report for 6thIncentive Award of the Society of Certifying Specialist in Internal Medicine, 1998.
Atoyama, et al., “Heikeigo Futei Shusorei ni Okeru Macrophage Activating Chinese Mixed Herbs (MACH) no Men'ekikei Inshi Chosei Sayo to Rinsho Koka”, Japanese Journal of Oriental medicine, vol. 54, pp. S118 and S247, (Apr. 2003).
Yamamoto, et al., “Taka Shibosan ni yoru Seitai Hanno Shushoku”, JJPEN, vol. 23, No. 6, Fig. 3, pp. 321-325, (2001).
Hayashi, et al., “Shinshuka ni Okeru n-3-Kei Shibo Nyuzai no Toyoryo ga Men'eki Hanno ni Ataeru Koka to Granulocyte-Macrophage Colony Stimulating Factor (GMCSF), no Kanyo”, The Japanese Journal of Surgical Metabolism and Nutrition, vol. 31, No. 4, Fig. 3, pp. 225-233, (1997).
Skrzypczak, et al., “M GM-CSF Influence the ability to fertilize oocyte?”, Ginekologia polska, vol. 70, No. 6, pp. 433-439, (1999).
Inukai, et al., “Benibanachu no Serotonin Yudotai no Enshosei Sansho Sogai Narabi ni Sen'l Ga Saibo Zoshoku Sayo”, Symposium on Toxicology and Environmental Health, vol. 25, p. 89, (1999).
Ushiroyama Takahisa
Yoshida Satoshi
Chen Catheryne
Finnegan Henderson Farabow Garrett & Dunner LLP
Flood Michele
Original Image Co., Ltd.
LandOfFree
Agent for increasing granulocyte macrophage colony... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Agent for increasing granulocyte macrophage colony..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agent for increasing granulocyte macrophage colony... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2714844